http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103958509-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
| filingDate | 2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103958509-B |
| titleOfInvention | As 3-(quinoline-6-base sulfo-)-[1,2,4] triazolo [4,3-A] pyridine compounds that the 6-of tyrosine kinase inhibitor replaces |
| abstract | The present invention relates to formula (I) compound and salt thereof, in formula (I), each substituting group with define in specification sheets identical, the invention still further relates to the purposes of formula (I) compound in the treatment mankind or animal body, particularly be used for the treatment of the purposes in the medicine of this type of disease, the medicinal compositions containing formula (I) compound by the tyrosine kinase mediated disease of c-Met or illness, formula (I) compound in production, optional containing combination pairing medicine in this medicinal compositions, the invention still further relates to the method for preparation formula (I) compound. |
| priorityDate | 2011-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 875.